Warner (India) Pharma Private Limited

Warner (India) Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U85191DL2007PTC171397 Incorporated 13 December 2007 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹34.07 Cr
▼ 2% YoY
Net profit · FY 2025
₹1.14 Lakh
Net margin 0%
EBITDA · FY 2025
₹95.22 Lakh
EBITDA margin 2.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
19 yrs
Est. 2007
Directors on board
3
As per MCA filings
Active GSTINs
3
GST registered

About Warner (India) Pharma Private Limited

Data last updated:

Warner (India) Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 December 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85191DL2007PTC171397. Its GSTIN is 07AAACW7893A1Z7 (Delhi). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gyanesh Jeswal and Ashutosh Goel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 27/2 Badli Industrial Estate Badli, New, Delhi, India – 110042.

As per the financials filed for FY 2025, the company reported a revenue of ₹34.07 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.14 Lakh (net margin 0%) and EBITDA of ₹95.22 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 649% over five years.

Court records list 4 cases involving the company, including 4 filed by the company; 4 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Warner (India) Pharma Private Limited
CIN U85191DL2007PTC171397
Registration Number 171397
Incorporation Date 13 December 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    M – 27/2 Badli Industrial Estate Badli, New, Delhi, India – 110042
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Warner (India) Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Warner (India) Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Warner (India) Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Warner (India) Pharma Private Limited

The main business activity of Warner (India) Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcyclesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Warner (India) Pharma Private Limited FY 2025 filings available

Warner (India) Pharma Private Limited reported revenue of ₹34.07 Cr (down 2% YoY) for FY 2025.

Revenue · FY 2025
₹34.07 Cr ▼ 2%
Net profit · FY 2025
₹1.14 Lakh margin 0%
EBITDA · FY 2025
₹95.22 Lakh margin 2.8%

Compounded Annual Growth Rate (CAGR) of Warner (India) Pharma Private Limited

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 7%
5 years · compounded
▲ 649%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 54%
5 years · compounded
▲ 511%

Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 649%. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Warner (India) Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹95.22 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.14 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Warner (India) Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.8%••••••••••••••••
Net Profit Margin0%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Warner (India) Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Warner (India) Pharma Private Limited

Warner (India) Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Raghavam Logistics Private Limited••••••••••••••••16Raipur, Chattisgarh, India
Medsol India Overseas Private Limited••••••••••••••••208Noida, Uttar Pradesh, India
Aril Bioscience Private Limited••••••••••••••••-Mumbai, Maharashtra, India
Drug Centre Delhi Private Limited••••••••••••••••-Delhi, India
Adinarayan Associates Private Limited••••••••••••••••-Cuttack, Orissa, India
Warner (India) Pharma Private Limited this company••••••••••••••••-New Delhi, Delhi, India
Materia Meditech Private Limited••••••••••••••••-Delhi, India
Ashok GNXT Pharma Private Limited••••••••••••••••46Vadodara, Gujarat, India
Gencor Pacific Organics India Private Limited••••••••••••••••-Chennai, Tamil Nadu, India
Isshaan Healthcare Private Limited••••••••••••••••-Delhi, India
Crystal Medical Centre Private Limited••••••••••••••••-Kanpur, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Warner (India) Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Warner (India) Pharma Private Limited

Warner (India) Pharma Private Limited is audited by NEHA PANDEY & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
NEHA PANDEY & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Warner (India) Pharma Private Limited

Warner (India) Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gyanesh JeswalDirector09 Oct 20205 Years 11 MonthsCurrent
Ashutosh GoelDirector28 Sep 20206 Years 0 MonthsCurrent
Mayank GoelDirector28 Sep 20206 Years 0 MonthsCurrent

Ownership and Shareholding of Warner (India) Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Warner (India) Pharma Private Limited

Warner (India) Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Warner (India) Pharma Private Limited

Employment history and EPFO contributions of people linked to Warner (India) Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Warner (India) Pharma Private Limited

Warner (India) Pharma Private Limited has 10 board changes on record since 2010: 3 appointments and 7 cessations. The latest: Ashutosh Goel ceased to be Additional Director on 31 Dec 2020.

AGM
Warner (India) Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Warner (India) Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Ashutosh Goel ceased to be Additional Director.
Ceased
Mayank Goel ceased to be Additional Director.
Appointed
Gyanesh Jeswal was appointed as Director.
Ceased
Amit Singla ceased to be Director.
Ceased
Arun Gupta ceased to be Director.
Appointed
Ashutosh Goel was appointed as Director.
Appointed
Mayank Goel was appointed as Director.
Ceased
Inder Singh Gupta ceased to be Director.
Ceased
Gyanesh Jeswal ceased to be Director.
Ceased
Naresh Kumar Goel ceased to be Director.

1 earlier event is listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Warner (India) Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Warner (India) Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Warner (India) Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Warner (India) Pharma Private Limited

Warner (India) Pharma has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
07AAACW7893A1Z7DelhiActive29 Oct 2020
08AAACW7893A1Z5RajasthanActive06 Apr 2023
09AAACW7893A1Z3Uttar PradeshActive13 Apr 2023
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Warner (India) Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Warner (India) Pharma Private Limited

Warner (India) Pharma is an active private limited company based in New, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 December 2007 (19+ years old) and is registered under CIN U85191DL2007PTC171397.

Warner (India) Pharma reported revenue of ₹34.07 Cr for FY 2025 (down 2% YoY).

Warner (India) Pharma has 3 current directors:

Warner (India) Pharma reported a net profit of ₹1.14 Lakh (net margin 0%) and EBITDA of ₹95.22 Lakh (EBITDA margin 2.8%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Warner (India) Pharma is 7% over three years and 649% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Warner (India) Pharma is 07AAACW7893A1Z7, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 08AAACW7893A1Z5 (Rajasthan), 09AAACW7893A1Z3 (Uttar Pradesh).

The CIN (Corporate Identification Number) of Warner (India) Pharma is U85191DL2007PTC171397. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Warner (India) Pharma has 4 court cases on record: 4 filed by the company. 4 are pending.

Warner (India) Pharma was incorporated on 13 December 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Warner (India) Pharma by revenue are Raghavam Logistics Private Limited, Medsol India Overseas Private Limited, Aril Bioscience Private Limited, Drug Centre Delhi Private Limited, Adinarayan Associates Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Ashutosh Goel ceased to be Additional Director on 31 Dec 2020. Mayank Goel ceased to be Additional Director on 31 Dec 2020. Gyanesh Jeswal was appointed as Director on 09 Oct 2020. Warner (India) Pharma has 10 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available